CoChat

Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants

Reid, S., Barbui, C. · 2010 · BMJ
Cited by 93

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

#### Summary points The introduction of fluoxetine in 1987 marked the arrival of the selective serotonin reuptake inhibitors (SSRIs) for the treatment for depression. In the United States antidepressant prescriptions accounted for 2.6% of primary care visits in 1989, rising to 7.1% in 2000.1 This pattern was reflected across Europe, where SSRIs are now the most commonly prescribed antidepressants. Newer antidepressants, such as the serotonin norepinephrine reuptake inhibitors, including venlafaxine and duloxetine, also contributed to the remarkable increase in antidepressant prescribing.2 Several reasons were put forward for this trend: improved tolerability; reduced lethality in overdose; the aggressive marketing of newly patented drugs; the wider range of available antidepressants; and ease of prescription. An analysis of the UK general practice research database showed that prescriptions almost doubled from 1993 to 2005.3 However, the increase in antidepressant prescribing was not accounted for by new diagnoses but rather a rise in the number of prescriptions given for long term treatment: although the proportion of patients receiving short term treatment declined, the proportion of patients receiving continuing prescriptions for over five years increased. Another primary care study found that …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.c1468

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 93

Metadata

Authors
Reid, S., & Barbui, C.
Venue
BMJ
Publisher
BMJ
Published
2010-03-26
Volume
340
Issue
mar26 1
Pages
c1468-c1468
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2000644842
Cited by
93
References
14
FWCI
5.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants. https://app.cochat.ai/papers/10.1136/bmj.c1468
The paper
Reid, S., & Barbui, C. (2010). Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants. BMJ. https://doi.org/10.1136/bmj.c1468

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.